GM-CSF R alpha

GM-CSF R alpha

GM-CSF R alpha 詳細

Molecule Name
Granulocyte-macrophage colony-stimulating factor receptor subunit alpha
分子の別称
GM-CSF R alpha,GM-CSF-R-alpha,GMCSFR-alpha,GMR-alpha,CSF2RA,CSF2R,CSF2RY,CDw116,CD116
Drug Development Progress
治験薬の数4
市販薬剤の数0
研究&開発段階Phase 3 Clinical
ターゲットの別称
GM-CSF-R-alpha,GMCSFR-alpha,GMR-alpha,CD116,Colony Stimulating Factor 2 Receptor Subunit Alpha,Colony Stimulating Factor 2 Receptor, Alpha, Low-Affinity (Granulocyte-Macrophage),CSF2R,CSF2RAX,CSF2RAY,CSF2RX,CSF2RY,GM-CSF Receptor Alpha Subunit,GMCSFR,GMR,Granulocyte-Macrophage Colony-Stimulating Factor Receptor Alpha Chain,SMDP4,Colony Stimulating Factor 2 Receptor Alpha Subunit,CDw116,CD116 Antigen,Alpha-GM-CSF Receptor,AlphaGMR
バックグランド
GM-CSF R alpha(Granulocyte-macrophage colony-stimulating factor receptor subunit alpha) is also known as CSF2RA, CD116, GMR-alpha. Low affinity receptor for granulocyte-macrophage colony-stimulating factor. Transduces a signal that results in the proliferation, differentiation, and functional activation of hematopoietic cells. Hereditary pulmonary alveolar proteinosis (hPAP) is a rare disorder of pulmonary surfactant accumulation and hypoxemic respiratory failure caused by mutations in CSF2RA (encoding the granulocyte/macrophage colony-stimulating factor [GM-CSF] receptor α-chain [CD116]), which results in reduced GM-CSF-dependent pulmonary surfactant clearance by alveolar macrophages.

GM-CSF R alpha 製品リスト

Species
  • Human(2)
  • Mouse(1)
Tag
  • His Tag(2)
  • Fc Tag(1)
Host
  • HEK293(3)
Conjugate
  • Unconjugated(3)
Grade
  • RUO(3)
Low Endotoxin
  • No(3)
MoleculeCat. No.Product Name種HostStructurePurityActivitySize&Price
GM-CSF R alpha
Human GM-CSF R alpha Protein, His Tag (SPR verified)
Human
HEK293
SDS-PAGE
ELISASPRBLI

$340.00

100ug
GM-CSF R alpha
Mouse GM-CSF R alpha Protein, His Tag
Mouse
HEK293
SDS-PAGE
ELISA

$360.00

100ug
GM-CSF R alpha
Human GM-CSF R alpha Protein, Fc Tag
Human
HEK293
SDS-PAGE
ELISABLI

$340.00

100ug
You Have Viewed 1-3 Of 3 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
MavrilimumabCAM-3001; KPL-301; GM-CSFR; CAM3001Phase 3 ClinicalCsl Ltd
Arthritis, Rheumatoid; Coronavirus Disease 2019 (COVID-19); Giant Cell Arteritis; Pneumonia
詳細
Anti-GMR CAR T-cell TherapyPhase 2 ClinicalKyoto Prefectural University Of Medicine, Shinshu University School of Medicine
Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Juvenile
詳細
CSF2RA gene-corrected macrophages(University of South Florida)Phase 2 ClinicalRussian Academy Of Medical Sciences
Pulmonary Alveolar Proteinosis
詳細
STSA-1005STSA-1005; STSA1005Phase 1 ClinicalStaidson(Beijing) Biopharmaceuticals Co Ltd
Coronavirus Disease 2019 (COVID-19)
詳細
Customer Reviews